跳至主要内容
临床试验/NCT05129930
NCT05129930已完成不适用

Fluid Overload and Pulmonary Function After Coloesophagoplasty in Children. Single-central Observational Study

Pirogov Russian National Research Medical University1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2020年12月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
40
试验地点
1
主要终点
duration of intensive care unit (ICU) stay

研究概览

简要总结

Esophageal atresia is a rare but severe malformation, and it requires early surgery. Coloesophagoplasty is surgical repair of the esophageal with an isoperistaltic transverse colon graft. In the postoperative period after coloesophagoplasty children require careful monitoring of fluid balance, because clinically significant fluid overload can lead to dysfunction of various organs and systems.

详细描述

Esophageal atresia (EA) is a defect of the embryogenesis of the laryngotracheal tube. There are isolated forms of EA and combinations with a tracheoesophageal fistula (TPF). Esophageal plastic surgery with an isoperistaltic transplant from the transverse colon was performed in children with EA. After this surgical intervention children require observation in the intensive care unit (ICU). During this period, infusion therapy satisfies physiological needs and compensates for physiological and pathological losses. However, it is not always possible to compensate for the body's fluid needs and maintain a normovolemic state. Thus, fluid overload develops. It is based on a pathophysiological process when severe operational stress leads to the damage of glycocalyx in the vascular wall. As a result, albumin freely passes into the interstitium, and oncotic pressure rises in tissues. Fluid overload in the intra- and postoperative period can be a factor in an unfavorable outcome, leading to organ damage, as well as death.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Retrospective

入排标准

年龄范围
1 Month 至 3 Years(Child)
性别
All
接受健康志愿者

入选标准

  • Аge from 1 month to 3 years
  • EA with / without
  • Tracheoesophageal fistula (TPF)
  • Сoloesophagoplasty.

排除标准

  • Аesophageal burn,
  • Oesophageal peptic stenosis,
  • Congenital heart disease
  • Cardiotonic support in the postoperative period
  • Renal malformations
  • Bacterial pneumonia in the postoperative period,
  • Bronchopulmonary malformations.

结局指标

主要结局

duration of intensive care unit (ICU) stay

时间窗: up to 30 days after the surgery

number of days in ICU after surgery before discharge

intraoperative fluid overload (IVF)

时间窗: during the surgery

((injected fluid (ml) - diuresis (ml) - blood loss (ml))/weight before surgery)\*100%

Fraction of Inspired Oxygen (FiO2)

时间窗: in the third postoperative day

Fraction of Inspired Oxygen (FiO2)

duration of ICU stay corrected to sedation

时间窗: up to 30 days after the surgery

duration of ICU stay corrected for the duration of sedation

duration of mechanical ventilation (MV)

时间窗: up to 30 days after the surgery

number of days of MV after surgery before switching to continuous positive airway pressure (CPAP)

fluid overload (FO) on the first postoperative day in the ICU

时间窗: during the first postoperative day, exclude intraoperative period

((injected fluid (ml)-lost fluid (ml))/weight before admission to ICU)\*100%

partial pressure of carbon dioxide (pC02)

时间窗: in the third postoperative day

partial pressure of carbon dioxide (pC02)

total fluid overload on the first postoperative day

时间窗: during the first postoperative day, include intraoperative period

((injected fluid (ml) - lost fluid (ml))/weight before surgery)\*100%

Oxygen saturation (Sp02)

时间窗: in the third postoperative day

Oxygen saturation (Sp02)

inspiratory pressure (Pin)

时间窗: in the third postoperative day

inspiratory pressure (Pin)

Positive end-expiratory pressure (PEEP)

时间窗: in the third postoperative day

Positive end-expiratory pressure (PEEP)

duration of MV corrected to sedation

时间窗: up to 30 days after the surgery

duration of MV corrected for the duration of sedation

Venous oxygen saturation (Svo2)

时间窗: in the third postoperative day

Venous oxygen saturation (Svo2)

次要结局

未报告次要终点

研究者

发起方
Pirogov Russian National Research Medical University
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验